ImmuCell Corp Files 8-K on Financials
Ticker: ICCC · Form: 8-K · Filed: Nov 13, 2025 · CIK: 811641
| Field | Detail |
|---|---|
| Company | Immucell Corp /De/ (ICCC) |
| Form Type | 8-K |
| Filed Date | Nov 13, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.10 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: ICCC
TL;DR
ImmuCell filed its 8-K detailing financial results and condition.
AI Summary
ImmuCell Corporation filed an 8-K on November 13, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits related to the company's performance. ImmuCell Corporation is incorporated in Delaware and its principal executive offices are located in Portland, Maine.
Why It Matters
This filing provides investors with crucial updates on ImmuCell Corporation's financial performance and operational results, enabling informed investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing (8-K) and does not indicate any immediate or significant risks.
Key Players & Entities
- ImmuCell Corporation (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Portland, Maine (location) — Principal executive offices
- 207-878-2770 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this Form 8-K filing for ImmuCell Corporation?
The primary purpose is to report on the Results of Operations and Financial Condition, and to file Financial Statements and Exhibits.
When was this Form 8-K filed?
This Form 8-K was filed on November 13, 2025.
Where are ImmuCell Corporation's principal executive offices located?
ImmuCell Corporation's principal executive offices are located at 56 Evergreen Drive, Portland, Maine, 04103.
What is ImmuCell Corporation's state of incorporation?
ImmuCell Corporation is incorporated in Delaware.
What is the IRS Employer Identification Number for ImmuCell Corporation?
The IRS Employer Identification Number for ImmuCell Corporation is 01-0382980.
Filing Stats: 537 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2025-11-13 16:07:40
Key Financial Figures
- $0.10 — ge on which registered Common Stock , $0.10 par value per share ICCC The Nasdaq
Filing Documents
- iccc20251113_8k.htm (8-K) — 36KB
- ex_888272.htm (EX-99.1) — 66KB
- 0001437749-25-034819.txt ( ) — 239KB
- iccc-20251113.xsd (EX-101.SCH) — 3KB
- iccc-20251113_def.xml (EX-101.DEF) — 11KB
- iccc-20251113_lab.xml (EX-101.LAB) — 15KB
- iccc-20251113_pre.xml (EX-101.PRE) — 11KB
- iccc20251113_8k_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition On November 13, 2025 ImmuCell Corporation (the "Company") issued a press release announcing its unaudited financial results for the quarter ended September 30, 2025. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K. The information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.
01. Exhibits
Item 9.01. Exhibits. (d) Exhibits . The following exhibit relating to Item 2.02 shall be deemed to be furnished, and not filed: 99.1 Press Release of the Company dated November 13, 2025. 104 Cover page Interactive Data File (embedded within the Inline XBRL document) 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IMMUCELL CORPORATION Date: November 13, 2025 By: /s/ Timothy C. Fiori Timothy C. Fiori Chief Financial Officer 2 Exhibit Index Exhibit No. Description 99.1 Press Release of the Company dated November 13 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 3